PD-L1 expression was associated with aggressive clinicopathological features in patients with VHL-related renal cell carcinoma

PD-L1 expression was associated with aggressive clinicopathological features in patients with VHL-related renal cell carcinoma

Bibliographic Details
Main Authors:	K.F. Ma, L. Li, Z. Kenan, K. Gong, L. Cai
Format:	Article
Language:	English
Published:	Elsevier 2020-07-01
Series:	European Urology Open Science
Online Access:	http://www.sciencedirect.com/science/article/pii/S2666168320329359

Similar Items

The Clinicopathological Significance of Epigenetic Silencing of VHL Promoter and Renal Cell Carcinoma: A Meta-Analysis
by: Lei Yang, et al.
Published: (2016-12-01)

Low VHL mRNA expression is associated with more aggressive tumor features of papillary thyroid carcinoma.
by: Boban Stanojevic, et al.
Published: (2014-01-01)

Clinicopathologic Significance of VHL Gene Alteration in Clear-Cell Renal Cell Carcinoma: An Updated Meta-Analysis and Review
by: Hyeong Su Kim, et al.
Published: (2018-08-01)

CpG methylation profiling in <it>VHL </it>related and <it>VHL </it>unrelated renal cell carcinoma
by: Clarke Noel W, et al.
Published: (2009-06-01)

Correlation analysis of VHL and Jade-1 gene expression in human renal cell carcinoma
by: Xiao-fen Wu, et al.
Published: (2016-01-01)

PD-L1 and PD-1 expression are correlated with distinctive clinicopathological features in papillary thyroid carcinoma
by: Yanhua Bai, et al.
Published: (2017-10-01)

Significance of VHL changes in sporadic renal cell carcinoma
by: Young, Alison Claire
Published: (2012)

8q24 clear cell renal cell carcinoma germline variant is associated with VHL mutation status and clinical aggressiveness
by: Jeanette E. Eckel-Passow, et al.
Published: (2020-10-01)

Spectrum of VHL mutations in clear cell renal cell carcinoma
by: N. N. Mazurenko, et al.
Published: (2020-11-01)

VHL dependent expression of REDD1 and PDK3 proteins in clear-cell renal cell carcinoma
by: Ilić Bojana B., et al.
Published: (2018-01-01)

Dissecting the effects of VHL mutations in VHL disease and sporadic clear cell renal carcinoma : linking functional consequences to clinical implications
by: Gossage, Lucy Mary
Published: (2014)

Role of the VHL and PTEN tumour suppressors in clear cell renal carcinoma
by: Barod, R.
Published: (2011)

PROGNOSTIC VALUE OF VHL GENE ALTERATION IN PATIENTS WITH METASTATIC RENAL CELL CARCINOMA
by: D. A. Nosov, et al.
Published: (2014-08-01)

PROGNOSTIC VALUE OF VHL GENE ALTERATION IN PATIENTS WITH METASTATIC RENAL CELL CARCINOMA
by: D. A. Nosov, et al.
Published: (2014-08-01)

Pretreatment BMI Is Associated with Aggressive Clinicopathological Features of Papillary Thyroid Carcinoma: A Multicenter Study
by: Shi-tong Yu, et al.
Published: (2017-01-01)

Risk factors for survival in patients with von Hippel-Lindau disease: A large single-center retrospective study of 734 VHL patients
by: K.F. Ma, et al.
Published: (2020-07-01)

Immunohistochemical expression and clinicopathological assessment of PD-1, PD-L1, NY-ESO-1, and MAGE-A4 expression in highly aggressive soft tissue sarcomas
by: Akagi, M., et al.
Published: (2022)

Trichloroethylene exposure and somatic mutations of the <it>VHL </it>gene in patients with Renal Cell Carcinoma
by: Fevotte Joelle, et al.
Published: (2007-11-01)

Translocation Renal Cell Carcinoma: An Update on Clinicopathological and Molecular Features
by: Kentaro Inamura
Published: (2017-08-01)

Clinicopathologic features of TDO2 overexpression in renal cell carcinoma
by: Quoc Thang Pham, et al.
Published: (2021-06-01)

Survivin Overexpression Is Associated with Aggressive Clinicopathological Features in Cervical Carcinoma: A Meta-Analysis.
by: Ke-Yan Cheng, et al.
Published: (2016-01-01)

The VHL-dependent regulation of microRNAs in renal cancer
by: Rawlings Lesley H, et al.
Published: (2010-10-01)

JunB promotes cell invasion and angiogenesis in VHL-defective renal cell carcinoma
by: Kanno, Toru
Published: (2012)

PD-L1 expression in Xp11.2 translocation renal cell carcinoma: Indicator of tumor aggressiveness
by: Kun Chang, et al.
Published: (2017-05-01)

The role of miRNA genes participating in VHL-HIF1α in clear cell renal cell carcinoma
by: V. N. Pavlov, et al.
Published: (2019-02-01)

Identification and Functional Characterization of pVHL-Dependent Cell Surface Proteins in Renal Cell Carcinoma
by: Gunther Boysen, et al.
Published: (2012-06-01)

Correlation of COX- 2 Expression in Colorectal Carcinoma with Clinicopathological Features
by: Sandhya VENKATACHALA, et al.
Published: (2017-09-01)

Clinicopathological Features of Triple Negative Breast Carcinoma
by: Gowry Maram Reddy, et al.
Published: (2017-01-01)

Renal tubular HIF-2α expression requires VHL inactivation and causes fibrosis and cysts.
by: Ruth E Schietke, et al.
Published: (2012-01-01)

Deciphering von Hippel-Lindau (VHL/Vhl)-associated pancreatic manifestations by inactivating Vhl in specific pancreatic cell populations.
by: H-C Jennifer Shen, et al.
Published: (2009-01-01)

The SWI/SNF Protein PBRM1 Restrains VHL-Loss-Driven Clear Cell Renal Cell Carcinoma
by: Amrita M. Nargund, et al.
Published: (2017-03-01)

Correlation between the Expression of PD-L1 and Clinicopathological Features in Patients with Thymic Epithelial Tumors
by: Yanmei Chen, et al.
Published: (2018-01-01)

VHL deficiency augments anthracycline sensitivity of clear cell renal cell carcinomas by down-regulating ALDH2
by: Yao-Hui Gao, et al.
Published: (2017-06-01)

Development and validation of a VHL-associated immune prognostic signature for clear cell renal cell carcinoma
by: Jin Zhang, et al.
Published: (2020-12-01)

Loss of vhl in the zebrafish pronephros recapitulates early stages of human clear cell renal cell carcinoma
by: Haley R. Noonan, et al.
Published: (2016-08-01)

Identification of Somatic Mutations in the von Hippel–Lindau (VHL) Gene in a Patient With Renal Cell Carcinoma
by: Wen-Chung Wang, et al.
Published: (2009-11-01)

VHL suppresses RAPTOR and inhibits mTORC1 signaling in clear cell renal cell carcinoma
by: Athina Ganner, et al.
Published: (2021-07-01)

MOLECULAR GENETIC DISORDERS IN THE VHL GENE AND METHYLATION OF SOME SUPPRESSOR GENES IN SPORADIC CLEAR-CELL RENAL CARCINOMAS
by: D. S. Mikhailenko, et al.
Published: (2014-07-01)

MOLECULAR GENETIC DISORDERS IN THE VHL GENE AND METHYLATION OF SOME SUPPRESSOR GENES IN SPORADIC CLEAR-CELL RENAL CARCINOMAS
by: D. S. Mikhailenko, et al.
Published: (2014-07-01)

Von Hippel-Lindau (VHL) inactivation in sporadic clear cell renal cancer: associations with germline VHL polymorphisms and etiologic risk factors.
by: Lee E Moore, et al.
Published: (2011-10-01)